Nuvectis Pharma, Inc. (NVCT) has 95 open-market insider trades by 8 insiders since 2022. Over the last six months insiders net bought $1.2M. The most active filer is Ron Bentsur, CEO & Chairman +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Marlio Charles Mosseri | 10% Owner | — | 26 | $12.1M | 2026-06-30 |
| Ron Bentsur | CEOChairman10% Owner | — | 47 | $3.3M | 2026-06-30 |
| Kenneth Hoberman | Dir | — | 1 | $209K | 2026-06-11 |
| Matthew L. Kaplan | Dir | — | 2 | $115K | 2026-06-11 |
| Shay Shemesh | Chief Dev. & Ops. Officer | — | 12 | $95K | 2026-01-06 |
| Juan Sanchez | Dir | — | 1 | $75K | 2026-06-11 |
| Enrique Poradosu | Chief Science & Business Off | — | 5 | $45K | 2026-01-06 |
| Michael J. Carson | PresVP | — | 1 | $22K | 2026-08-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ron Bentsur | CEO & Chairman +1 | Buy | $250K | 2026-06-30 |
| Marlio Charles Mosseri | 10% Owner | Buy | $916K | 2026-06-30 |
| Juan Sanchez | Director | Buy | $75K | 2025-11-05 |
| Ron Bentsur | Chairman & 10% | Buy | $29K | 2025-11-05 |
| Matthew L. Kaplan | Director | Buy | $64K | 2025-11-05 |
| Marlio Charles Mosseri | 10% Owner | Buy | $1.6M |
Companies that share insiders with NVCT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2025-10-23 |
| Marlio Charles Mosseri | 10% | Buy | $45K | 2025-06-20 |
| Marlio Charles Mosseri | 10% Owner | Buy | $495K | 2025-06-17 |
| Marlio Charles Mosseri | 10% Owner | Buy | $343K | 2025-05-12 |
| Marlio Charles Mosseri | 10% Owner | Buy | $423K | 2025-05-08 |
| Marlio Charles Mosseri | 10% Owner | Buy | $405K | 2025-05-06 |
| Marlio Charles Mosseri | 10% Owner | Buy | $1.2M | 2025-02-07 |
| Ron Bentsur | Chairman & 10% | Buy | $21K | 2024-12-24 |
| Marlio Charles Mosseri | 10% Owner | Buy | $378K | 2024-12-12 |
| Enrique Poradosu | Chief Science & Business Off | Buy | $10K | 2024-11-19 |